hims hers glp 1 & set for Super Bowl ad debut highlighting GLP-1 weight loss drugs Hims & Hers shares rally

Patients switching from tirzepatide to semaglutide should expect somewhat reduced appetite suppression and potentially slower weight loss, given that they are moving from a dual agonist to a single agonist

What is remarkable about GLP-1 receptor agonist drugs is that they mimic this natural incretin hormone so precisely that the pancreas only responds when blood sugar is actually elevated

Sharma R, McDonald TS, Eng H, et al

FDA Press Release on Jascayd Converting More Prescription Drugs to Nonprescription Drugs The two most recent prescription drugs to become available over-the-counter (OTC) in the U.S

4.3.2 RCTs In RCTs ( Table 1 ) (5261), weight loss was observed in all trials, except with albiglutide